Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.

[1]  L. Lybarger,et al.  Requirements for the Selective Degradation of Endoplasmic Reticulum-Resident Major Histocompatibility Complex Class I Proteins by the Viral Immune Evasion Molecule mK3 , 2005, Journal of Virology.

[2]  L. Lybarger,et al.  Model for the Interaction of Gammaherpesvirus 68 RING-CH Finger Protein mK3 with Major Histocompatibility Complex Class I and the Peptide-Loading Complex , 2004, Journal of Virology.

[3]  L. K. Ely,et al.  Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion , 2004, The Journal of experimental medicine.

[4]  P. Cresswell,et al.  Cellular mechanisms governing cross-presentation of exogenous antigens , 2004, Nature Immunology.

[5]  T. Rapoport,et al.  A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol , 2004, Nature.

[6]  H. Ploegh,et al.  A membrane protein required for dislocation of misfolded proteins from the ER , 2004, Nature.

[7]  R. Dwek,et al.  Major Histocompatibility Complex Class I Molecules Expressed with Monoglucosylated N-Linked Glycans Bind Calreticulin Independently of Their Assembly Status* , 2004, Journal of Biological Chemistry.

[8]  T. Elliott,et al.  The processing of antigens delivered as DNA vaccines , 2004, Immunological reviews.

[9]  U. Koszinowski,et al.  Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 , 2004, The Journal of Immunology.

[10]  P. Lehner,et al.  Viral degradation of the MHC class I peptide loading complex. , 2004, Immunity.

[11]  P. Cresswell,et al.  Recent developments in MHC-class-I-mediated antigen presentation. , 2004, Current opinion in immunology.

[12]  K. Früh,et al.  Downregulation of Major Histocompatibility Complex Class I by Human Ubiquitin Ligases Related to Viral Immune Evasion Proteins , 2004, Journal of Virology.

[13]  M. Wagner,et al.  Cytomegalovirus Misleads Its Host by Priming of CD8 T Cells Specific for an Epitope Not Presented in Infected Tissues , 2004, The Journal of experimental medicine.

[14]  H. Ploegh,et al.  Structural and Functional Analysis of Human Cytomegalovirus US3 Protein , 2004, Journal of Virology.

[15]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[16]  J. L. Petersen,et al.  Virus Evasion of MHC Class I Molecule Presentation1 , 2003, The Journal of Immunology.

[17]  E. Hewitt.  The MHC class I antigen presentation pathway: strategies for viral immune evasion , 2003, Immunology.

[18]  J. Brodsky,et al.  Evolving questions and paradigm shifts in endoplasmic‐reticulum‐associated degradation (ERAD) , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  D. Wolf,et al.  For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.

[20]  H. Hotta,et al.  c-MIR, a Human E3 Ubiquitin Ligase, Is a Functional Homolog of Herpesvirus Proteins MIR1 and MIR2 and Has Similar Activity* , 2003, The Journal of Biological Chemistry.

[21]  G. McFadden,et al.  The PHD/LAP-Domain Protein M153R of Myxomavirus Is a Ubiquitin Ligase That Induces the Rapid Internalization and Lysosomal Destruction of CD4 , 2003, Journal of Virology.

[22]  R. Dwek,et al.  Identification of Specific Glycoforms of Major Histocompatibility Complex Class I Heavy Chains Suggests That Class I Peptide Loading Is an Adaptation of the Quality Control Pathway Involving Calreticulin and ERp57* , 2002, The Journal of Biological Chemistry.

[23]  David C. Johnson,et al.  Inhibition of HLA-DR Assembly, Transport, and Loading by Human Cytomegalovirus Glycoprotein US3: a Novel Mechanism for Evading Major Histocompatibility Complex Class II Antigen Presentation , 2002, Journal of Virology.

[24]  J. Yewdell,et al.  Viral interference with antigen presentation , 2002, Nature Immunology.

[25]  J. Yewdell.  To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins. , 2002, Molecular immunology.

[26]  U. Koszinowski,et al.  K3-mediated evasion of CD8+ T cells aids amplification of a latent γ-herpesvirus , 2002, Nature Immunology.

[27]  P. Lehner,et al.  Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101‐dependent degradation , 2002, The EMBO journal.

[28]  James McCluskey,et al.  Optimization of the MHC class I peptide cargo is dependent on tapasin. , 2002, Immunity.

[29]  L. Lybarger,et al.  Physical Association of the K3 Protein of Gamma-2 Herpesvirus 68 with Major Histocompatibility Complex Class I Molecules with Impaired Peptide and β2-Microglobulin Assembly , 2002, Journal of Virology.

[30]  D. Ganem,et al.  A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition , 2001, The Journal of cell biology.

[31]  R. Tampé,et al.  Molecular Mechanism and Structural Aspects of Transporter Associated with Antigen Processing Inhibition by the Cytomegalovirus Protein US6* , 2001, The Journal of Biological Chemistry.

[32]  P. Stevenson,et al.  MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.

[33]  G. Hassink,et al.  Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. , 2001, The Biochemical journal.

[34]  T. Rapoport,et al.  Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. , 2001, Molecular biology of the cell.

[35]  D. Wiley,et al.  Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Lehner,et al.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP , 2001, The EMBO journal.

[37]  M. Garcia-Peydró,et al.  Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire1 , 2001, The Journal of Immunology.

[38]  P. Lehner,et al.  Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Ganem,et al.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Jae U. Jung,et al.  Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.

[41]  P. A. Peterson,et al.  Human Cytomegalovirus Immediate Early Glycoprotein US3 Retains MHC Class I Molecules by Transient Association , 2000, Traffic.

[42]  S. Jonjić,et al.  The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus against T Cell Control in Vivo , 1999, The Journal of experimental medicine.

[43]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[44]  P. Cresswell,et al.  HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. , 1998, Immunity.

[45]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[46]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[48]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[49]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[50]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. A. Peterson,et al.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Andrews,et al.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. , 1996, The EMBO journal.

[53]  P. A. Peterson,et al.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. , 1996, The EMBO journal.

[54]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[55]  M. Knop,et al.  Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. , 1996, The EMBO journal.

[56]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[57]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[58]  P. A. Peterson,et al.  Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance , 1985, Cell.

[59]  H. Burgert,et al.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens , 1985, Cell.

[60]  K. Früh,et al.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.

[61]  J. Bennink,et al.  A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. , 2003, Viral immunology.

[62]  H. Virgin,et al.  Virus subversion of the MHC class I peptide-loading complex. , 2003, Immunity.

[63]  M. Bouvier.  Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. , 2003, Molecular immunology.

[64]  P. Cresswell,et al.  Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. , 2002, Immunity.

[65]  T. Elliott,et al.  Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. , 2002, Immunity.

[66]  F. Momburg,et al.  Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. , 2002, Current topics in microbiology and immunology.

[67]  R. Tampé,et al.  Herpes viral proteins blocking the transporter associated with antigen processing TAP--from genes to function and structure. , 2002, Current topics in microbiology and immunology.